Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 GBX | 0.00% | +7.55% | +14.00% |
04-03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
03-27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Sales 2022 | 72.77M 90.9M 7.28B | Sales 2023 | 59.59M 74.43M 5.96B | Capitalization | 7.13M 8.91M 713M |
---|---|---|---|---|---|
Net income 2022 | -13M -16.24M -1.3B | Net income 2023 | -43M -53.71M -4.3B | EV / Sales 2022 | 1.7 x |
Net cash position 2022 | 9.99M 12.47M 999M | Net Debt 2023 | 21.14M 26.41M 2.11B | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-9.69
x | P/E ratio 2023 |
-0.16
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.79% |
1 week | +7.55% | ||
Current month | -5.00% | ||
1 month | -5.00% | ||
3 months | +14.00% | ||
6 months | +96.55% | ||
Current year | +14.00% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Llobet
CEO | Chief Executive Officer | 60 | 30/06/09 |
Shaun Furlong
DFI | Director of Finance/CFO | - | 31/03/22 |
Murray Skinner
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 05/06/17 | |
Peter Jensen
CHM | Chairman | 73 | 30/09/10 |
Anthony Parker
BRD | Director/Board Member | - | 05/12/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.85 | 0.00% | 515,871 |
25/04/24 | 2.85 | 0.00% | 850,862 |
24/04/24 | 2.85 | +1.79% | 919,062 |
23/04/24 | 2.8 | -1.75% | 948,754 |
22/04/24 | 2.85 | +7.55% | 668,040 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+14.00% | 169M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AGY Stock